Logos Global Management »

Alkermes shares owned by Logos Global Management

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $14M 500k 28.76

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences Call Option (IDYA)
Akero Therapeutics (AKRO)
Arvinas Ord (ARVN)
Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Verastem Com New (VSTM)
Abivax Sa Sponsored Ads (ABVX)
Janux Therapeutics (JANX)
Erasca (ERAS)
Maze Therapeatics (MAZE)
Olema Pharmaceuticals (OLMA)
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Disc Medicine (IRON)

View all positions for Logos Global Management

Top funds holding Alkermes

BlackRock
Vanguard Group
State Street Corporation
Baker Bros. Advisors
Renaissance Technologies
American Century Companies
Geode Capital Management
Jpmorgan Chase & Co
Dimensional Fund Advisors
Commodore Capital
PRIMECAP Management Company
Holocene Advisors
venBio Select Advisor
Nuveen
Charles Schwab Investment Management

View all funds holding Alkermes